Innovating Works

SISTEMIC

A stranger
REGENER-AR: Bringing Regenerative Medicine into the market Allogeneic eASCs Phase IB IIA clinical trial for tre... SISTEMIC SCOTLAND LIMITED participó en un FP7: Treating Rheumatoid Arthritis (RA) is a crucial challenge for the health systems. RA is the most common inflammatory arthritis, affecting 0....
financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.